• Dissecting Aneugenic Mechanisms: Flow Cytometry and Machine

  2026-06-26

  The referenced study establishes a robust tiered assay combining flow cytometry and machine learning to differentiate aneugenic mechanisms in vitro. This approach reliably identifies molecular targets such as tubulin destabilization, stabilization, and mitotic kinase inhibition, offering significant improvements for genotoxicity assessment workflows.

• SC 79: Strategic Cytosolic Akt Activation for Translational

  2026-06-25

  This article explores the strategic deployment of SC 79, a potent cytosolic Akt activator, as a transformative tool for translational research in neuroprotection and oncology. By dissecting its unique mechanism and integrating recent findings from ferroptosis studies, we provide actionable guidance for researchers seeking to unlock new therapeutic strategies in ischemic stroke and cancer biology. Practical protocol recommendations, evidence-based insights, and a critical review of the evolving landscape position SC 79 from APExBIO as an essential asset for those advancing the frontiers of Akt signaling pathway research.

• AP20187: Precision Control of Tumor Microenvironment Signali

  2026-06-25

  Explore how AP20187, a chemical inducer of dimerization, enables unparalleled regulation of protein interactions in cancer research, with a special focus on microenvironment and immune modulation. This article offers advanced insights for conditional gene therapy activators beyond standard protocols.

• Palonosetron hydrochloride: Precision in 5-HT3A/AB Antagonis

  2026-06-24

  This article provides scenario-driven guidance for biomedical researchers evaluating Palonosetron hydrochloride (SKU B2229) in cell-based assays and translational oncology. It addresses reproducibility, mechanistic specificity, and vendor selection, offering practical, evidence-based insights for optimizing antiemetic and transporter inhibition workflows with this highly selective 5-HT3 receptor antagonist.

• Mechanisms of GPER1 Inhibition by BHPF in Neuroblastoma Cell

  2026-06-23

  This study elucidates a novel inhibitory mechanism of fluorene-9-bisphenol (BHPF) on G protein-coupled estrogen receptor 1 (GPER1), highlighting its impact on apoptosis in human neuroblastoma cells. The findings offer critical insight into GPER1-targeted signaling and the health risks associated with emerging environmental contaminants.

• Disentangling Proliferative Arrest and Death in Cancer Drug

  2026-06-23

  Schwartz's dissertation advances in vitro cancer drug evaluation by rigorously distinguishing proliferative arrest from cell death, leading to greater assay interpretability and translational value. These insights are essential for benchmarking apoptosis-targeting compounds and refining preclinical research strategies.

• Novel HER2 Inhibitors Target EMT in Breast Cancer: Mubritini

  2026-06-22

  This study reports the synthesis and evaluation of a new series of HER2 inhibitors, using Mubritinib as a lead scaffold, and demonstrates that the novel compound Q7j surpasses Mubritinib in suppressing breast cancer cell proliferation and migration by modulating the EMT pathway. The findings highlight mechanistic insights into HER2 signaling and EMT regulation, informing future cancer biology and inhibitor development.

• Dissecting Jasmonate Signaling in Arabidopsis via Bestatin I

  2026-06-22

  This study demonstrates how bestatin, a selective aminopeptidase inhibitor, enables chemical genetic dissection of jasmonate (JA) signaling in Arabidopsis. By revealing JA pathway dependencies and identifying new regulatory loci, the work advances our understanding of plant defense signaling and offers methodological parallels for cytoskeletal research.

• Nanoplastics and Cadmium Trigger Apoptosis via IP3R/Ca2+/STA

  2026-06-21

  The referenced study demonstrates that co-exposure to polystyrene nanoplastics and cadmium induces apoptosis in intestinal cells by activating the IP3R/Ca2+/STAT3 signaling pathway. Using both C. elegans and Caco-2 cell models, the research reveals a mechanistic link between environmental co-contaminant exposure and calcium-dependent cell death, offering important implications for toxicological risk assessment and experimental design in apoptosis research.

• BRD4 Inhibition, UFMylation, and Ferroptosis Sensitivity in

  2026-06-20

  This study uncovers how BET bromodomain inhibition, specifically via JQ1, increases cancer cell sensitivity to ferroptosis by suppressing histone H4 UFMylation through upregulation of TXNIP. The findings redefine the interplay between epigenetic modulation and ferroptotic vulnerability, with implications for combination therapies targeting resistant solid tumors.

• Metoprolol in Translational Research: Optimized Protocols &

  2026-06-19

  Metoprolol, a selective beta1-adrenoceptor antagonist, empowers researchers with precise control over cardiovascular, inflammatory, and tumor biology pathways. Explore advanced experimental workflows, comparative advantages, and troubleshooting strategies that transform APExBIO’s Metoprolol into a cornerstone for translational breakthroughs.

• Capsaicin: Mechanistic Insights and Translational Strategy

  2026-06-19

  Explore the dual mechanistic profile of (E)-Capsaicin as both a TRPV1 ion channel activator and a potent, reversible inhibitor of lysine-specific demethylase 1A (KDM1A/LSD1). This article, anchored by leading studies and APExBIO's rigorously validated capsaicin product, guides translational researchers through state-of-the-art protocols, competitive positioning, and future directions at the intersection of pain, inflammation, and cancer epigenetics research.

• Heptamethine Cyanine Dye Targets PGR in HR+ Breast Cancer

  2026-06-18

  This study introduces CA800-PR, a tumor-targeted heptamethine cyanine dye, which selectively suppresses progesterone receptor (PGR) activity and induces Golgi fragmentation in hormone receptor-positive breast cancer. The findings highlight a multifunctional therapeutic approach that integrates targeted imaging, direct antitumor effects, and immune activation, offering a promising alternative to standard endocrine therapies.

• Bafilomycin C1 in High-Content Phenotypic Screening: Beyond

  2026-06-18

  Explore how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, enables next-generation phenotypic screening and mechanistic assays in cellular models. This article provides deep scientific insight, practical protocols, and unique analysis for advanced autophagy and cardiotoxicity research.

• Diethylmaleate (SKU B6151): Precision in Oxidative Stress Re

  2026-06-17

  This article explores laboratory challenges in modeling oxidative stress and resistance, demonstrating how Diethylmaleate (SKU B6151) is a validated, high-purity tool for reproducible glutathione depletion and GST inhibition. Scenario-driven Q&A blocks ground best practices in real data and literature, guiding researchers in redox regulation and toxicology workflows with actionable insights.

446 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page